Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

Diabetes Res Clin Pract. 2012 Mar;95(3):e49-51. doi: 10.1016/j.diabres.2011.11.008. Epub 2011 Dec 1.

Abstract

Post-prandial hyperglycaemia is a particular problem for some patients with diabetes despite administering continuous subcutaneous insulin infusion (CSII) to deliver insulin flexibly. We describe two cases of patients on CSII with persistent post-prandial hyperglycaemia despite varying insulin doses and timing. Treatment with acarbose improved their glycaemic control.

Publication types

  • Case Reports

MeSH terms

  • Acarbose / therapeutic use*
  • Adult
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Female
  • Glycoside Hydrolase Inhibitors
  • Humans
  • Hyperglycemia / drug therapy*
  • Hypoglycemic Agents / therapeutic use
  • Infusions, Subcutaneous
  • Insulin / therapeutic use
  • Middle Aged
  • Postprandial Period

Substances

  • Glycoside Hydrolase Inhibitors
  • Hypoglycemic Agents
  • Insulin
  • Acarbose